← All organizations

Cerevel Therapeutics, LLC

For profitWebsite ↗

Also known as: Cerevel Therapeutics, LLC

Highest phase reached

Phase 3

First clinical trial

Oct 15, 2019

Last known activity

May 29, 2024

Acquired by AbbVie on Dec 7, 2023

Timeline

2010s

  1. Jan 1, 2018

    Cerevel Therapeutics, LLC— Founded

2020s

  1. Dec 7, 2023

    AbbVie— Acquired By

Drugs by trial phase (15 distinct, 37 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Indications

Recent trials (50)

Details

Founded
Boston, MA, US Jan 1, 2018
Last known activity
May 29, 2024